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Cross-space-time clustering of childhood cancer in Great
Britain: Evidence for a common aetiology
Richard J.Q. McNally 1, Charles Stiller2, Tim J. Vincent2 and Michael F.G. Murphy2
1 Institute of Health and Society, Newcastle University, England, United Kingdom
2 Childhood Cancer Research Group, Department of Paediatrics, University of Oxford, England, United Kingdom
Previously, we identified space-time clustering in certain childhood cancers. This study aimed to determine whether there was
cross-space-time clustering between different diagnostic groups. A total of 32,295 cases were diagnosed during 1969–1993.
Cross-space-time clustering was analyzed by a second-order procedure based on Diggle’s method. Locations were birth and
diagnosis addresses. The following space-time combinations were examined: address and date of birth; address at birth and
date of diagnosis; address and date of diagnosis. Cross-space-time clustering analyses considered clustering pairs of cases
from two different diagnostic groups. Formal statistical significance was taken as p < 0.00067 and marginal significance 0.01
> p  0.00067. Based on address at birth and date of diagnosis, there was statistically significant cross-clustering between
cases of HL and intracranial and intraspinal embryonal tumors (IIET), both aged 0–14 years (p < 0.0001). Based on address
and date of birth, there was marginally significant cross-clustering between cases of lymphoid leukemia (LL) aged 5-14 years
and Hodgkin lymphoma (HL) aged 0–14 years (p 5 0.0019). Based on address and date of diagnosis there was marginally sig-
nificant cross-clustering between cases of LL aged 1–4 years and soft tissue sarcoma (STS) aged 0–14 years (p 5 0.0041).
Findings from this study are consistent with possible common aetiological factors between different diagnostic groups. They
suggest a common aetiology for the following pairs of diagnostic groups: HL and IIET; older cases of LL and HL; younger cases
of LL and STS. The possibility of common infectious mechanisms should be explored.
Space-time clustering occurs when excess numbers of cases
of cancer are observed within small geographical locations at
limited periods and this cannot be attributed to general
excesses in those locations or at those times. We have previ-
ously demonstrated statistically significant space-time cluster-
ing for certain childhood cancers diagnosed in Great Britain
during the period 1st January 1969 to 31st December 1993.
Analyses based on address and date of birth found space-
time clustering for cases of Hodgkin lymphoma (HL, aged
0–14 years) and central nervous system (CNS) tumor (aged
0–14 years). Analyses based on address at birth and date of
diagnosis found space-time clustering for cases of leukemia
(ages 1–4 years), lymphoma (ages 0–14 years), non-Hodgkin
lymphoma (NHL, ages 0–14 years), NHL (ages 0–9 years)
and Wilms tumor (ages 0–14 years).1 Analyses based on
address and date of diagnosis found space-time clustering for
cases of leukemia (ages 0–14 years), lymphoid leukemia (LL,
ages 0–14 years), LL (ages 1–4 years), soft tissue sarcoma
(STS, ages 0–14 years) and osteosarcoma (ages 0–14 years).2
Additionally, other regional studies from the UK support
findings of space-time clustering amongst cases of leukemia,
CNS tumor, STS and Wilms tumor.3–7 Together, these find-
ings support the involvement of transient environmental
exposures in aetiology.
In general, the aetiology of childhood cancer is not clear.
Both genetic predisposition and environmental exposure are
likely to be involved, but the former only directly accounts
for 5% of total cases.8 Preconception, in-utero or postnatal
environmental exposures could all be implicated. It has been
suggested that at least two events are required to trigger the
onset of a tumor.9,10 A role for infections as the agent
responsible for triggering the final event has been demon-
strated for certain lymphomas11 and postulated for childhood
leukemia, CNS tumors and sympathetic nervous system
tumors.12–15 Support for a possible infectious aetiology for
STS is suggested by the causal link between HHV8 and
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Kaposi’s sarcoma, in the presence of HIV infection.16 Associ-
ations with parental farming and residence on a farm suggest
that infections may play a part in the development of bone
cancer.17 By contrast, there is little evidence supporting a role
for infections in the aetiology of Wilms tumor.18
Given that a number of childhood cancers exhibit space-
time clustering and have an environmental (possibly infec-
tious) component to aetiology, it is plausible that some (or
all) of these different diagnostic groups may share a common
aetiology. Only one other smaller study has considered this
possibility. A previous, more limited, regional study from
northwest England found evidence of cross-space-time clus-
tering between cases of childhood leukemia (especially LL)
and CNS tumors (especially astrocytoma). This was inter-
preted as suggesting a common (possibly infectious) aetiolog-
ical mechanism.19
The aim of this study was to test predictions of cross-
space-time clustering, which might arise as a result of a com-
mon, possible infectious environmental exposure. The study
has major strengths. First, it is the largest and most compre-
hensive study of cross-space-time clustering to date. Second,
it uses high quality population-based national incidence data
on all childhood cancers, diagnosed with almost complete
ascertainment.
Material and Methods
Cases
All cases diagnosed with childhood cancer during the
period 1st January 1969 to 31st December 1993 and regis-
tered by the National Registry of Childhood Tumours
(NRCT) were included in the study. Anonymous case
details were obtained from the NRCT, which is
population-based and covers the whole of the UK (Eng-
land, Wales, Scotland and Northern Ireland).20 Birth
addresses were obtainable for 92% of registered cases.
This analysis was restricted to cases resident in Great Brit-
ain (England, Wales and Scotland) at time of diagnosis.
There were 10 twin pairs. For each twin pair, the earlier
diagnosed case was included and the later diagnosed case
was excluded from the analysed data sets.
Diagnostic classification
Cases were divided into diagnostic groups using the Interna-
tional Classification of Childhood Cancer, Third Edition
(ICCC-3).21 Diagnostic groups specified a priori for analysis
were the following: (i) LL [ICCC-3 code I (a)], ages 1–4
years; (ii) LL [ICCC-3 code I (a)], ages 5–14 years; (iii) HL
[ICCC-3 code II (a)]; (iv) NHL [ICCC-3 code II (b)]; (v)
astrocytoma [ICCC-3 code III (b)]; (vi) intracranial and
intraspinal embryonal tumors [IIET, ICCC-3 code III (c)];
(vii) soft tissue and other extraosseous sarcomas (STS, ICCC-
3 code IX); (viii) osteosarcoma [ICCC-3 code VIII (a)]; and
(ix) renal tumors (ICCC-3 code VI). Cases of LL were
divided into two age-groups because cases of the precursor
B-cell sub-type dominate the child peak that occurs at ages
1–4 years, whilst cases aged 5–14 years comprise a more
mixed set of LL subtypes.22
Grid references
Ordnance Survey (OS) provides grid-based maps for the
whole of Great Britain (England, Wales and Scotland). For
each childhood cancer case, 4-digit Easting and 4-digit
Northing OS grid references were assigned to the centroids
of the address post-codes at time of birth and at time of
diagnosis. This enabled spatial referencing of the Easting and
Northing coordinates of both the address at birth and the
address at diagnosis to the nearest 0.1 km. To preserve confi-
dentiality of locations, without compromising the analyses,
grid references had their origin shifted and have been
rotated.
Prior hypotheses
The following aetiological hypotheses were tested:
• (i) Some of the following groups will share a common envi-
ronmental aetiology: LL (ages 1–4 years) LL (ages 5–14
years), HL, NHL, astrocytoma, IIET, STS and osteosarcoma;
• (ii) Renal tumors will not share an environmental aetiology
with other tumor groups.
Space-time combinations
The following space-time combinations were examined:
address and date of birth, address at birth and date of diag-
nosis and address and date of diagnosis. The interpretation
of these interactions has been given in detail previously.3 A
space-time interaction between addresses and dates of birth
suggests the involvement of an exposure close to the location
of birth, occurring in utero or soon after birth. It would
What’s new?
The clustering of childhood cancers within specific geographical areas of Great Britain between 1969 and 1993 has raised
questions about the possible etiological involvement of environmental exposures. Here, cross-space-time clustering analysis
was used to explore associations between different childhood cancers diagnosed in the region during the 1ST January 1969 to
31ST December 1993 is a 25-year period. Significant clustering was identified between cases of Hodgkin lymphoma and
intracranial and intraspinal embryonal tumors, while marginal clustering was observed between lymphoid leukemia and
Hodgkin lymphoma and between lymphoid leukemia and soft tissue sarcoma. The findings support the idea that common
etiological factors could explain the clustering of these different cancers.
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indicate a variable latent period between initial exposure and
onset of overt disease. A space-time interaction between
addresses at birth and dates of diagnosis would suggest an
exposure at heterogeneous times after birth with a short or at
least constant latent period. A space-time interaction between
addresses and dates of diagnosis would suggest the involve-
ment of an exposure close to the location of diagnosis, occur-
ring close to time of diagnosis.
Statistical methods
Cross-space-time clustering analyses were applied to test for
associations between pairs of cases from different diagnostic
groups. For these analyses, the test is concerned with cluster-
ing pairs “x, y,” where “x” represents a case from one diag-
nostic group and “y” represents a case from a different
diagnostic group.
The Knox test has been used for many analyses of space-
time clustering.23 A generalized version of the Knox test,
based on the method of Diggle et al.,24 was used to analyse
cross-space-time clustering, consistent with our previously
published analyses.1,2 For a pair of cases, in the Knox test, if
dates of an event (birth or diagnosis) are close and residential
addresses (at time of birth or diagnosis) are close, then that
pair is said to be in “close proximity.” The numbers of cross-
pairs of cases observed to be in close proximity is counted
(Ox,y) and the expected number of cross-pairs is calculated
(Ex,y). If Ox,y is larger than Ex,y, a significance test is used to
determine if there is space-time clustering. “Strength of
clustering” is estimated by calculating Sx,y 5 ([Ox,y 2 Ex,y]/
Ex,y) 3 100.
3 It should be noted that the overall observed
number of pairs of cases that are in the close proximity in the
combined group is O 5 Ox,x 1 Oy,y 1 Ox,y, where Ox,x and
Oy,y are the observed numbers of pairs of cases that are in
close proximity within diagnostic groups “x” and “y,” respec-
tively. Similarly, the overall expected number in the combined
group is E 5 Ex,x 1 Ey,y 1 Ex,y, where Ex,x and Ey,y are the
numbers of pairs of cases that are expected to be in close
proximity within diagnostic groups “x” and “y,” respectively.
Arbitrary choice of critical values for defining close prox-
imity presents a problem with the Knox test. Also, repeated
testing using a number of different critical values would lead
to multiple testing. A simplification of the method of Diggle
et al. was used, thereby partially overcoming the arbitrary
choice of critical values and avoiding multiple testing.24 This
approach involved a set of 225 calculations, similar to the
Knox test. Other analyses have used critical values changed
over a prespecified set (for time: t 5 0.1, 0.2, . . ., 1.5 years
and for space: s 5 0.5, 1, . . ., 7.5 km).2–7 Analyses based on
a nearest neighbor (NN) are more likely to be appropriate
when there is heterogeneity in population density, such as
when both urban and rural localities are included. To allow
for variation in population density, we replaced the fixed geo-
graphical distances by variable distances to the (N 2 7)th,
. . ., (N 1 7)th NNs. This method is similar to one originally
proposed by Jacquez.25 In this study, we have only used the
NN method. Thus, the main analyses are based on the
method of Diggle et al., with the space-time K-statistic com-
puted at equally spaced time, but nonequally spaced distan-
ces. For birth locations, the mean distance between the 25th
NNs was 5 km, so the set of fixed distance critical values
(0.5, 1, 1.5, . . ., 7.5 km) were replaced by variable NN critical
values (distances between the 18th, . . ., 32nd NNs). For diag-
nosis locations, the mean distance between the 26th NNs was
5 km, so fixed critical distances were replaced by variable
NN values (distances between the 19th, . . ., 33rd NNs). For
close times, we used the set of critical values: 0.1, 0.2, . . ., 1.5
years.
A quantity Rx,y (s, t) 5 (Ox,y 2 Ex,y)/Ex,y is defined.
Then the observed value of the K-statistic is calculated as KO
5
P
Rx,y (s, t), summed over all 225 critical pairs of values
for s and t. Since the distribution of the K-statistic is not
known, it is estimated by simulation using 999 random tem-
poral permutations. For those analyses where p < 0.001 we
used 9,999 simulations. A realization of the K-statistic was
obtained at each simulation by randomly reallocating the
dates of the event (birth or diagnosis) to each of the cases in
the analysis. Comparison of the observed value with the
simulated distribution allowed statistical significance to be
assessed, using a one-sided test. To allow for multiple testing,
the level of formal statistical significance in all analyses was
taken as p < 0.00067 (determined as 0.05/75).26 Marginal sig-
nificance was defined as 0.01 > p  0.00067.
Since the K-statistic does not provide a measure of the
magnitude of an effect, Sx,y, determined from the Knox test is
given as an indication of magnitude (with critical values for
closeness in space taken as distances between 25th NNs for
births, 26th NNs for diagnoses and for closeness in time as 1
year). It should be noted that it is possible for a small value
of Sx,y to result when the real effect is large if space-time
clustering occurs at a different scale (note that to simplify
notation “Sx,y” is denoted “S” in subsequent parts of this
report).
The distributions of distances between both birth and
diagnosis locations were highly skewed. To test whether pop-
ulation density was associated with cross-space-time cluster-
ing, separately for birth and diagnosis locations, cases were
split into two groups: 50% were classified as belonging to a
“more densely populated” group and 50% were classified as
belonging to a “less densely populated” group on the basis of
whether the 25th (for births) or 26th (for diagnoses) NN was
nearer or further away than the median distance of the 25th
or 26th NN. Analysis by population density was then done
by considering cross-clustering pairs that included at least 1
case from the “more densely populated” category and cross-
clustering pairs that included at least 1 case from the “less
densely populated” category. It must be noted that analyses
of population density (especially analyses of “less densely
populated: any” cross-clustering pairs) may be diluted due to
edge effects since “less densely populated” areas are some-
times not contiguous.
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K-statistic and Knox analyses were run using programs
written in FORTRAN (note that K-statistic analyses can also
be run using the Splancs package in R).27–29
Results
The dataset included 32,295 cases of childhood cancer, with
complete diagnosis data (address and date) and 29,553 cases
with complete birth data (address and date). Only groups
for which there were clear prior hypotheses were analysed
(Table 1).
Using place of birth and date of diagnosis (Table 2) there
was statistically significant cross-space-time clustering
between cases of HL and IIET (p < 0.0001; S 5 35.20%).
Using place and date of birth (Table 3) there was marginally
significant cross-space-time clustering between cases of LL
(ages 5–14 years) and HL (p 5 0.0019; S 5 19.27%). Using
place and date of diagnosis (Table 3) there was marginally
significant cross-space-time clustering between cases of LL
(ages 1–4 years) and STS (p 5 0.0041; S 5 11.09%). Results
of analyses of space-time clustering based on “more densely
populated: any” and “less densely populated: any” clustering
pairs are presented (Tables 4 and 5). There was significant
cross-space-time clustering between cases of HL and IIET,
which was significant for “more densely populated: any” clus-
tering pairs (p 5 0.0004, S 5 82.08%) and marginally signifi-
cant for “less densely populated: any” clustering pairs (p 5
0.0039, S 5 82.44%; Table 5). There was marginally signifi-
cant cross-space-time clustering between cases of LL (5–14
years) and HL, which was confined to “more densely popu-
lated: any” clustering pairs (p 5 0.0028, S 5 61.02% Table
4a).
Discussion
The analyses have been performed using well specified statis-
tical methods on very good quality population-based inci-
dence data. It is the largest study of cross-space-time
clustering that has been done, analyzing 32,295 cases. Highly
novel statistically significant cross-space-time clustering has
been identified between cases of HL and IIET; and marginally
significant cross-space-time clustering between cases of LL
(ages 5–14 years) and HL; and LL (ages 1–4 years) and STS.
Thus there was support for the first prior hypothesis that
some of the following groups will share a common environ-
mental aetiology: LL (ages 1–4 years), LL (ages 5–14 years),
HL, NHL, astrocytoma, IIET, STS and osteosarcoma, since all
of these apart from NHL, astrocytoma and osteosarcoma
demonstrated some evidence of cross-space-time clustering.
There was also support for the second prior hypothesis that
renal tumors will not share an environmental aetiology with
Table 1. Numbers of cases for analyses of cross-space-time clustering of childhood cancer in Great Britain, 1969–1993
Total Males Females
Diagnostic group Birth Diagnosis Birth Diagnosis Birth Diagnosis
LL(ages 1–4) 4,140 4,343 2,361 2,483 1,779 1,860
LL(ages 5–14) 3,335 3,810 1,939 2,216 1,396 1,594
HL 1,226 1,364 851 953 375 411
NHL 1,485 1,678 1,050 1,192 435 486
Astrocytoma 2,614 2,824 1,306 1,422 1,308 1,402
IIET 1,410 1,548 889 976 521 572
STS 1,921 2,101 1,083 1,185 838 916
Osteosarcoma 669 811 334 408 335 403
Renal tumors 1,820 1,889 920 945 900 944
HL: Hodgkin lymphoma; IIET: intracranial and intraspinal embryonal tumors; LL: lymphoid leukemia; NHL: non-Hodgkin lymphoma; STS: soft tissue
sarcomas.
Table 2. Cross-space-time clustering of cases of HL and NHL with
other diagnostic groups
Diagnostic groups
Place of
birth and
date of
birth
Place of
birth and
date of
diagnosis
Place of
diagnosis
and date of
diagnosis
HL 3 NHL p 5 0.91 p 5 0.58 p 5 0.73
HL 3 Astrocytoma p 5 0.42 p 5 0.30 p 5 0.10
HL 3 IIET p 5 0.31 p < 0.00011
(S 5 35.20%)
p 5 0.69
HL 3 STS p 5 0.05 p 5 0.55 p 5 0.68
HL 3 Osteosarcoma p 5 0.60 p 5 0.72 p 5 0.34
HL 3 Renal tumors p 5 0.99 p 5 0.87 p 5 0.71
NHL 3 Astrocytoma p 5 0.34 p 5 0.03 p 5 0.24
NHL 3 IIET p 5 0.27 p 5 0.50 p 5 0.73
NHL 3 STS p 5 0.22 p 5 0.04 p 5 0.18
NHL 3 Osteosarcoma p 5 0.41 p 5 0.12 p 5 0.87
NHL 3 Renal tumors p 5 0.63 p 5 0.69 p 5 0.95
1Statistically significant, defined as p < 0.00067.
HL: Hodgkin lymphoma; IIET: intracranial and intraspinal embryonal
tumors; NHL: non-Hodgkin lymphoma; S: strength of clustering
([{observed 2 expected}/expected] 3 100%, counts of pairs that are
close in space and time); STS: soft tissue sarcomas.
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other tumor groups, since renal tumors did not cross-cluster
with any other group.
The finding of significant cross-clustering between cases of
HL and IIET indicates that cases of these two distinct diag-
nostic groups occur together at similar places of birth and
similar times of diagnosis. This suggests the aetiological
involvement of a common transient exposure at heterogene-
ous times after birth with a short or at least constant latent
period. The analyses indicated that both urban and rural
localities were involved. A previous study from Yorkshire
identified space-time clustering amongst cases of IIET.7 A
number of transient environmental agents may play a role,
including pesticides, insecticides, pollutants and infections.
However, infections are a plausible candidate as they have
been implicated in both diseases.13,30–33
The finding of marginally significant cross-clustering
between cases of LL (ages 5–14 years) and HL indicates that
cases of these two distinct diagnostic groups occur together at
similar places and times of birth. This suggests that these diag-
noses may share a common transient aetiological factor,
occurring in utero or around the time of birth. Furthermore,
cross-clustering was confined to clustering pairs that included
at least one case from a “more densely populated” area, sug-
gesting an association with more urban locations. In marked
contrast, there was no evidence of cross-clustering between
cases of LL (ages 1–4 years) and HL. This indicates that
younger cases of LL may not share a common aetiological fac-
tor with cases of HL. We interpret these findings in the context
of other epidemiological evidence regarding the aetiology of
LL and HL. Younger cases of LL, forming the childhood peak,
mainly comprise the precursor B-cell subtype, whilst older
cases have a greater mixture of subtypes.22 Greaves suggested
that the precursor B-cell subtype has a distinctive aetiology
related to delayed exposure to common infections.10 Smith
also proposed that in utero exposure to infection is responsible
for the childhood peak in LL (which is mostly precursor B-
cell).34 There is a lack of similar distinctive hypotheses con-
cerning nonprecursor B-cell LL. Kinlen proposed that child-
hood leukemia excesses are linked with very unusual
population mixing, but did not specify the subtype or age
range.35,36 For LL no single agent has been conclusively linked
to aetiology.12 In contrast, HL has been linked with specific
direct transforming infectious agents, including Epstein-Barr
virus.31,32 EBV is especially associated with paediatric cases
and the mixed cellularity subtype.37,38 Our finding of cross-
clustering, involving urban settings, suggests that some older
paediatric cases of LL (possibly nonprecursor B-cell) may arise
due to the same directly transforming agent as some cases of
HL. Furthermore, the time of exposure (in utero or around the
time of birth) suggests that there is a long latency until occur-
rence of overt disease. Other events are also likely to be
involved in the process, as postulated by Knudson.9 It is also
possible that other transient environmental exposures may be
implicated including pesticides, fungicides, benzene, consump-
tion of seasonal fruit and vegetables.11
The finding of marginally significant cross-clustering
between cases of LL (ages 1–4 years) and STS indicates that
cases of these two distinct diagnostic groups occur together
at similar places and times of diagnosis. This suggests the
aetiological involvement of a common transient exposure
around the time of diagnosis. Conversely, there was no evi-
dence of cross-clustering between cases of LL (ages 5–14
Table 3. Cross-space-time clustering of cases of LL with other diagnostic groups
Diagnostic groups
Place of birth and
date of birth
Place of birth and
date of diagnosis
Place of diagnosis and
date of diagnosis
LL (ages 1–4) 3 HL p > 0.9999 p 5 0.67 p 5 0.79
LL (ages 1–4) 3 NHL p 5 0.9998 p 5 0.47 p 5 0.52
LL (ages 1–4) 3 Astrocytoma p 5 0.93 p 5 0.67 p 5 0.93
LL (ages 1–4) 3 IIET p 5 0.94 p 5 0.46 p 5 0.90
LL (ages 1–4) 3 STS p 5 0.46 p 5 0.51 p 5 0.00411 (S 5 11.09%)
LL (ages 1–4) 3 Osteosarcoma p 5 0.99 p 5 0.43 p 5 0.29
LL (ages 1–4) 3 Renal tumors p 5 0.89 p 5 0.53 p 5 0.80
LL (ages 5–14) 3 HL p 5 0.00191 (S 5 19.27%) p 5 0.59 p 5 0.43
LL (ages 5–14) 3 NHL p 5 0.21 p 5 0.17 p 5 0.54
LL (ages 5–14) 3 Astrocytoma p 5 0.77 p 5 0.25 p 5 0.78
LL (ages 5–14) 3 IIET p 5 0.46 p 5 0.62 p 5 0.46
LL (ages 5–14) 3 STS p 5 0.75 p 5 0.80 p 5 0.92
LL (ages 5–14) 3 Osteosarcoma p 5 0.39 p 5 0.81 p 5 0.28
LL (ages 5–14) 3 Renal tumors p 5 0.77 p 5 0.65 p 5 0.93
1Marginally significant, defined as 0.01 > p  0.00067.
HL: Hodgkin lymphoma; IIET: intracranial and intraspinal embryonal tumors; LL: lymphoid leukemia; NHL: non-Hodgkin lymphoma; S: strength of
clustering ([{observed 2 expected}/expected] 3 100%, counts of pairs that are close in space and time).
STS, soft tissue sarcomas
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years) and STS. This suggests that older cases of LL may
not arise from the same common aetiology as cases of STS.
It has been postulated that younger cases of LL, which
comprise the childhood peak and are mainly of the precur-
sor B-cell subtype, arise from delayed exposure to common
infections.10 There are no similar mechanisms suggested for
STS. However, infectious links for STS are plausible, since
HHV8 (in the presence of HIV) is causally associated with
Kaposi’s sarcoma.16 Other transient environmental expo-
sures that have been implicated in the aetiology of STS
include occupational chemicals, phenoxyacetic acid herbi-
cides, chlorophenols and dioxin.39 The present finding sug-
gests that, at least for some cases, the final event
precipitating a LL (in those aged 1–4 years) or STS (ages
0–14 years) may arise from the same environmental agent
(possibly an infection).
A previous study from northwest England found cross-
clustering between LL and astrocytoma.19 In this national
study, we did not find such an association. If localized tran-
sient agents (such as infections) are involved in aetiology,
then it may be predicted that some links are only found in
certain geographical regions. Thus, findings from this
national study do not necessarily refute the earlier region-
specific results, although some could have arisen by chance.
Table 4. Cross-space-time clustering of cases of LL with other diagnostic groups, by level of population density
Diagnostic groups
Place of birth and
date of birth
Place of birth and
date of diagnosis
Place of diagnosis and
date of diagnosis
(a) “More densely populated: any” cross-clustering pairs
LL (ages 1–4) 3 HL p 5 0.9998 p 5 0.31 p 5 0.43
LL (ages 1–4) 3 NHL p 5 0.9992 p 5 0.31 p 5 0.71
LL (ages 1–4) 3 Astrocytoma p 5 0.72 p 5 0.71 p 5 0.84
LL (ages 1–4) 3 IIET p 5 0.96 p 5 0.68 p 5 0.72
LL (ages 1–4) 3 STS p 5 0.77 p 5 0.46 p 5 0.02
LL (ages 1–4) 3 Osteosarcoma p 5 0.97 p 5 0.77 p 5 0.06
LL (ages 1–4) 3 Renal tumors p 5 0.76 p 5 0.36 p 5 0.71
LL (ages 5–14) 3 HL p 5 0.00281
(S 5 61.02%)
p 5 0.18 p 5 0.80
LL (ages 5–14) 3 NHL p 5 0.34 p 5 0.18 p 5 0.64
LL (ages 5–14) 3 Astrocytoma p 5 0.28 p 5 0.32 p 5 0.73
LL (ages 5–14) 3 IIET p 5 0.12 p 5 0.91 p 5 0.87
LL (ages 5–14) 3 STS p 5 0.68 p 5 0.54 p 5 0.77
LL(ages 5–14) 3 Osteosarcoma p 5 0.16 p 5 0.59 p 5 0.62
LL (ages 5–14) 3 Renal tumors p 5 0.86 p 5 0.55 p 5 0.95
(b) “Less densely populated: any” cross clustering pairs
LL (ages 1–4) 3 HL p 5 0.98 p 5 0.88 p 5 0.89
LL (ages 1–4) 3 NHL p 5 0.998 p 5 0.69 p 5 0.23
LL (ages 1–4) 3 Astrocytoma p 5 0.90 p 5 0.68 p 5 0.89
LL (ages 1–4) 3 IIET p 5 0.56 p 5 0.25 p 5 0.73
LL (ages 1–4) 3 STS p 5 0.48 p 5 0.69 p 5 0.02
LL (ages 1–4) 3 Osteosarcoma p 5 0.84 p 5 0.20 p 5 0.44
LL (ages 1–4) 3 Renal tumors p 5 0.87 p 5 0.51 p 5 0.85
LL (ages 5–14) 3 HL p 5 0.05 p 5 0.77 p 5 0.14
LL (ages 5–14) 3 NHL p 5 0.28 p 5 0.48 p 5 0.60
LL (ages 5–14) 3 Astrocytoma p 5 0.98 p 5 0.17 p 5 0.84
LL (ages 5–14) 3 IIET p 5 0.56 p 5 0.10 p 5 0.18
LL (ages 5–14) 3 STS p 5 0.37 p 5 0.95 p 5 0.97
LL (ages 5–14) 3 Osteosarcoma p 5 0.93 p 5 0.80 p 5 0.07
LL (ages 5–14) 3 Renal tumors p 5 0.72 p 5 0.39 p 5 0.85
1Marginally significant, defined as 0.01 > p  0.00067.
HL: Hodgkin lymphoma; IIET: intracranial and intraspinal embryonal tumors; LL: lymphoid leukemia; NHL: non-Hodgkin lymphoma; S: strength of
clustering ([{observed – expected} / expected] 3 100%, counts of pairs that are close in space and time); STS: soft tissue sarcomas
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However, it should be noted that there will be some overlap
as a number of the cases in the earlier regional studies from
northwest England will also be present in this national study.
The study has some limitations. It must be acknowledged
that temporal trends in the incidence of certain childhood can-
cers may be at least partly influenced by improvements in diag-
nostic techniques.40 However, such changes will occur over
widespread geographical regions are so are highly unlikely to
induce artefactual space-time clustering. The cases were diag-
nosed via the National Health Service in the UK. This is a
socialized heath care system with uniform systems and univer-
sal coverage. All data were obtained from the NRCT, which has
almost complete ascertainment. Thus it is not plausible that
diagnostic changes at a local scale would have led to the pat-
terns observed. The choice of the formal significance level of
p < 0.00067 has guarded against the possible effect of multiple
testing leading to spurious nominally significant results. How-
ever, strictly adjusting for multiple testing may be too conserva-
tive. Therefore, we also defined 0.01 > p  0.00067 as
marginally significant, acknowledging that chance may have
played a role in some of these findings. It is possible that appa-
rent space-time clustering may be seen due to shifts in small-
area populations over short time periods. A method for adjust-
ment for this type of population shift has been suggested by
Kulldorff and Hjalmars.41 Unfortunately, data on small-area
populations for short time periods are not available in GB.
Thus, it was not possible to make any adjustments for such
putative population shifts. However, statistically significant
cross-space-time clustering was specific to particular pairs of
diagnostic groups, for which there is some evidence for an envi-
ronmental (especially infectious) origin. The distinctive find-
ings of cross-space-time clustering provide a strong argument
against the possibility that population shifts have led to these
observations.
Table 5. Cross-space-time clustering of cases of HL and NHL with other diagnostic groups, by level of population density
Diagnostic groups
Place of birth and
date of birth
Place of birth and
date of diagnosis
Place of diagnosis and
date of diagnosis
(a) “More densely populated: any” cross-clustering pairs
HL 3 NHL p 5 0.77 p 5 0.37 p 5 0.55
HL 3 Astrocytoma p 5 0.25 p 5 0.74 p 5 0.43
HL 3 IIET p 5 0.40 p 5 0.00041
(S 5 82.08%)
p 5 0.81
HL 3 STS p 5 0.34 p 5 0.34 p 5 0.64
HL 3 Osteosarcoma p 5 0.31 p 5 0.95 p 5 0.45
HL 3 Renal tumors p 5 0.69 p 5 0.46 p 5 0.29
NHL 3 Astrocytoma p 5 0.03 p 5 0.02 p 5 0.15
NHL 3 IIET p 5 0.76 p 5 0.53 p 5 0.86
NHL 3 STS p 5 0.49 p 5 0.31 p 5 0.57
NHL 3 Osteosarcoma p 5 0.47 p 5 0.14 p 5 0.71
NHL 3 Renal tumors p 5 0.74 p 5 0.84 p 5 0.90
(b) “Less densely populated: any” cross-clustering pairs
HL 3 NHL p 5 0.92 p 5 0.86 p 5 0.38
HL 3 Astrocytoma p 5 0.75 p 5 0.11 p 5 0.07
HL 3 IIET p 5 0.53 p 5 0.00392
(S 5 82.44%)
p 5 0.35
HL 3 STS p 5 0.02 p 5 0.71 p 5 0.67
HL 3 Osteosarcoma p 5 0.69 p 5 0.25 p 5 0.58
HL 3 Renal tumors p 5 0.996 p 5 0.97 p 5 0.98
NHL 3 Astrocytoma p 5 0.87 p 5 0.15 p 5 0.53
NHL 3 IIET p 5 0.10 p 5 0.60 p 5 0.67
NHL 3 STS p 5 0.20 p 5 0.0107 p 5 0.14
NHL 3 Osteosarcoma p 5 0.18 p 5 0.15 p 5 0.52
NHL 3 Renal tumors p 5 0.42 p 5 0.35 p 5 0.84
1Statistically significant, defined as p < 0.00067.
2Marginally significant, defined as 0.01 > p  0.00067.
HL: Hodgkin lymphoma; IIET: intracranial and intraspinal embryonal tumors; NHL: non-Hodgkin lymphoma; S: strength of clustering ([{observed –
expected}/expected] 3 100%, counts of pairs that are close in space and time); STS: soft tissue sarcomas.
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In conclusion, the analyses have been performed on
high quality population-based incidence data using appro-
priate statistical methods. The highly novel findings of
cross-space-time clustering from this study are consistent
with possible common aetiological factors between differ-
ent diagnostic groups. Although these findings should be
treated tentatively, specifically they suggest a common
aetiology for the following pairs of diagnostic groups: HL
and IIET; older cases of LL and HL; and younger cases
of LL and STS. For cross-clustering groups, the possibil-
ity of common infectious mechanisms should be
explored.
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